Your browser doesn't support javascript.
loading
Harnessing the Versatility of Optical Biosensors for Target-Based Small-Molecule Drug Discovery.
Kaminski, Tim; Gunnarsson, Anders; Geschwindner, Stefan.
Afiliação
  • Kaminski T; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, S-43183 Mölndal, Sweden.
  • Gunnarsson A; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, S-43183 Mölndal, Sweden.
  • Geschwindner S; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, S-43183 Mölndal, Sweden.
ACS Sens ; 2(1): 10-15, 2017 Jan 27.
Article em En | MEDLINE | ID: mdl-28722441
ABSTRACT
Optical biosensors entered target-based small-molecule drug discovery more than two decades ago and have since transformed into a value-adding component in the decision-making process. Here, we briefly highlight the major application areas of optical biosensors and focus on desirable profiles of such platforms in order to ensure their effective use in small molecule drug discovery. Furthermore, we will emphasize current technology-based constraints and discuss experimental strategies to address these limitations as well as provide a view of necessary technology improvements for next generation platforms.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Sens Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Sens Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia